SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-016117
Filing Date
2021-11-17
Accepted
2021-11-17 07:21:04
Documents
108
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20210930x10q.htm   iXBRL 10-Q 3664467
2 EX-31.1 jagx-20210930xex31d1.htm EX-31.1 11026
3 EX-31.2 jagx-20210930xex31d2.htm EX-31.2 11025
4 EX-32.1 jagx-20210930xex32d1.htm EX-32.1 6972
5 EX-32.2 jagx-20210930xex32d2.htm EX-32.2 6947
  Complete submission text file 0001558370-21-016117.txt   15622187

Data Files

Seq Description Document Type Size
6 EX-101.SCH jagx-20210930.xsd EX-101.SCH 131642
7 EX-101.CAL jagx-20210930_cal.xml EX-101.CAL 78798
8 EX-101.DEF jagx-20210930_def.xml EX-101.DEF 684745
9 EX-101.LAB jagx-20210930_lab.xml EX-101.LAB 917109
10 EX-101.PRE jagx-20210930_pre.xml EX-101.PRE 883689
11 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20210930x10q_htm.xml XML 2440260
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 211418409
SIC: 2834 Pharmaceutical Preparations